Bausch+Lomb Results Presentation Deck

Building a Global Dynamic Dry Eye Disease Platform Artelac Rebalance Artelac Rebalance Artelac Artelac 20 He 10 Aug Artelac BAUSCH + LOMB Artelac Complete MDO >35 countries launched 10+ line extensions Dry Eye It is estimated that more than 16M patients in the U.S. are diagnosed with Dry Eye Disease ¹ mmste REVALET CORE Bio true MOIRATION FOGST INESHEE ORDRE SEOVERFLOMS Bio true REMICHOLONG Bio true INVORATION 201 Expanding the Biotrue® Mega Brand TWIN PACK BAUSCH + LOMB SootheXP Emot en Luonconveces XTRA 1. Farrand et al. Prevalence of Diagnosed Dry Eye Disease in the United States Among Adults Aged 18 Years and Older. Am J Ophthalmol 2017; 182:90-98. 2. Investigational treatment. 3. See Slide 1 for further information on forward-looking statements. 4. Revenue number is inclusive of our entire dry eye platform. Twelve months ended 3/31/2023. PROTECTION Advanced Dry Eye heropy | Reptome Goal Protest Sterile 2x15L BOTTES 12.50 EACHI Total Revenue for Global Dry Eye Platform 4:~$250 M BAUSCH LOMB Soothe Lubricant eyeonment NIGHTTIME PRESERVATIVE FRE Dry Eye Therapy pm): For nighttime relief of severe dry eye NET WT 1/1 02 (3.5) Our Next Catalyst: NOV032 PDUFA date (June 28, 2023)³ BAUSCH LOMS Soothe Lubricant Eye O HYDRATION Dry Eye Therapy 1 Moisturizes I Comforts I Protects Sterile 85 FL 02 (15 ml) 14

View entire presentation